Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARIX BIOSCIENCE PLC Director's Dealing 2018

Mar 21, 2018

4968_dirs_2018-03-21_b6748424-2a96-4cc8-a25c-2913a7b443f0.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4574I

Arix Bioscience Plc

21 March 2018

21 March 2018

ARIX BIOSCIENCE PLC

Director/PDMR Shareholding

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Jonathan Peacock
2 Reason for the notification
a) Position / status Chairman
b) Initial notification /

Amendment
Initial Notification
3 Details of issuer
a) Name Arix Bioscience plc
b) LEI 213800OVT3AHQCXNIX43
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of Arix Bioscience plc
Identification code GB00BD045071
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
225.00 pence 90,000
d) Aggregated information Aggregated price Aggregated volume
N/A (single transaction) N/A (single transaction)
e) Date of the transaction 20 March 2018
f) Place of the transaction London Stock Exchange (XLON)

For further information:

James Rawlingson                           Chief Financial Officer                +44 (0)207 290 1050

- Ends -

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFFLFLVXFXBBD